Latest news
Is Opus Genetics Inc (IRD) Significantly Overvalued After Q2 Ear - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:48:49 GMTOpus Genetics (NASDAQ:IRD) Upgraded at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:03 GMTOpus Genetics (IRD) Stock Stalls As Revenue Shrinks And Losses Deepen - simplywall.stsimplywall.st · Sat, 08 Aug 2026 02:03:01 GMTOpus Genetics price target lowered to $9 from $10 at RBC Capital - TipRanksTipRanks · Fri, 07 Aug 2026 23:27:59 GMTOpus Genetics (NASDAQ: IRD) sets $300M shelf and $125M ATM stock plan - Stock TitanStock Titan · Fri, 07 Aug 2026 10:57:57 GMTOpus Genetics, Inc. 2Q 2026: Revenue $0.8M, EPS $(0.14) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTOpus Genetics (Nasdaq: IRD) hit by $73.6M loss, rising warrant costs - Stock TitanStock Titan · Thu, 06 Aug 2026 20:32:59 GMTOpus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:20:07 GMT